Safety, tolerability and pharmacokinetics of AFN-1252 administered as immediate release tablets in healthy subjects.
about
Antibiotics in the clinical pipeline at the end of 2015.A Pathogen-Selective Antibiotic Minimizes Disturbance to the Microbiome.Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure-activity relationship analyses.Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 - 2015).Safety, tolerability and pharmacokinetics of multiple oral doses of AFN-1252 administered as immediate release (IR) tablets in healthy subjects.
P2860
Safety, tolerability and pharmacokinetics of AFN-1252 administered as immediate release tablets in healthy subjects.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety, tolerability and pharm ...... e tablets in healthy subjects.
@en
type
label
Safety, tolerability and pharm ...... e tablets in healthy subjects.
@en
prefLabel
Safety, tolerability and pharm ...... e tablets in healthy subjects.
@en
P2093
P2860
P356
P1433
P1476
Safety, tolerability and pharm ...... e tablets in healthy subjects.
@en
P2093
Barry Hafkin
Nachum Kaplan
Thomas L Hunt
P2860
P304
P356
10.2217/FMB.15.101
P577
2015-09-11T00:00:00Z